Iranian Journal of Neurology 2017. 16(4):218-220.

Height, shape and anterior-posterior diameter of pituitary gland on magnetic resonance imaging among patients with multiple sclerosis compared to normal individuals
Mohammad Saba, Hossein Ali Ebrahimi, Habibeh Ahmadi-Pour, Mohammad Khodadoust


Background: Several studies indicate contribution of hypothalamus-pituitary-adrenal (HPA) axis in multiple sclerosis (MS) disease. This study was designed to determine whether there is an effective difference in pituitary height, shape, and anterior-posterior diameter (APD) between patients with MS and the control group.

Methods: In this study, sagittal pituitary height and APD of 134 men and women (64 patients with MS and 70 healthy subjects as control group) were measured by T1 sequence magnetic resonance imaging (MRI). All the subjects were free of sellar or parasellar pathology without a history of surgical intervention or prolactin affecting drugs like bromocriptine and cabergoline or corticosteroid consumption.

Results: Mean height of pituitary gland was
6.62 ± 1.43 and 5.78 ± 1.15 mm for patients and the control group, respectively, and the difference between the two groups was statistically significant (P = 0.001). Mean APD was 10.40 ± 1.29 mm for the group of patients and 10.25 ± 1.41 mm for the control group, respectively, without significant differences. 46.9%, 37.5%, and 15.6% of patients had flat, convex, and concave hypophyseal surfaces, respectively. This rate was 50%, 30%, and 20%
among the control group, respectively. There
was no significant difference between our
measurements among patients on whom imaging study was performed at time of disease onset
with others.

Conclusion: Mean height of pituitary gland among patients with MS was significantly greater than the control group (P = 0.001). So can we consider the same etiology for pituitary hypertrophy among patients with MS as a hypothesis?


Multiple Sclerosis; Pituitary; Height; Shape; Magnetic Resonance Imaging

Full Text:



Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. N Engl J Med. 2000 Sep 28;343(13):938-52.

Mohammad Ali Shafa, M.D.1, Hossein Ali Ebrahimi, M.D.2*, Narges Khanjani, P.hD.3 A Study of the Seasonal Incidence of Multiple Sclerosis Attacks in Kerman, Iran. Journal of Kerman University of Medical Sciences, 2014; 21(5): 376-383

Etemadifar M1, Izadi S, Nikseresht A, Sharifian M, Sahraian MA, Nasr Z. Estimated prevalence and incidence of multiple sclerosis in Iran. Eur Neurol. 2014;72(5:370-4. doi: 10.1159/000365846. Epub 2014 Oct 18.

Ebrahimi HA, Sedighi B. Prevalence of multiple sclerosis and environmental factors in Kerman province, Iran. Neurology Asia 2013; 18(4): 385-9.

O'connor, T. M., D. J. O'halloran, and F. Shanahan. "The stress response and the hypothalamic- pituitary‐adrenal axis: from molecule to melancholia." Qjm 93.6 (2000): 323-333.

Michelson D, Stone L, Galliven E, Magiakou MA, Chrousos GP, Sternberg EM, et al. Multiple sclerosis is associated with alterations in hypothalamic-pituitary-adrenal axis function. J Clin Endocrinol Metab. 1994 Sep;79(3):848-53.

Saba Mohamad1, Ebrahimi Hosseinali1, Ahmadipour Habibeh2, Khodadoust M Mohamad *3The mean height and anteroposterior diameter and shape of a normal pituitary gland in a sample population at the age group of 15-40. Pars Journal of Medical Sciences, Vol. 13, No.2, Summer 2015

Heesen C, Mohr DC, Huitinga I, Bergh FT, Gaab J, Otte C, et al. Stress regulation in multiple sclerosis: current issues and concepts. Mult Scler. 2007 Mar;13(2):143-8.

Tsunoda A, Okuda O, Sato K. MR height of the pituitary gland as a function of age and sex: especially physiological hypertrophy in adolescence and in climacterium. AJNR Am J Neuroradiol. 1997 Mar;18(3):551-4.

Gottschalk M, Kumpfel T, Flachenecker P, Uhr M, Trenkwalder C, Holsboer F, et al. Fatigue and regulation of the hypothalamo-pituitary-adrenal axis in multiple sclerosis. Arch Neurol. 2005 Feb;62(2):277-80.

Jafarzadeh A, Ebrahimi HA, Bagherzadeh S, Zarkesh F, Iranmanesh F, Najafzadeh A, et al. Lower serum levels of Th2-related chemokine CCL22 in women patients with multiple sclerosis: a comparison between patients and healthy women. Inflammation. 2014 Apr;37(2):604-10.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.